Use of Cool Water Packs To Prevent Freezing During Vaccine Transportation at the Country Level

References

1. 1.↵
   1. Milstien J.,
   2. Kartoglu U.,
   3. Zaffran M.

   Temperature sensitivity of vaccines. World Health Organization: Geneva, 2006. WHO document WHO/IVB/06.10.
2. 2.↵
   World Health Organization. The effects of freezing on the appearance, potency, and toxicity of adsorbed and unadsorbed DTP vaccines. Weekly Epidemiological Record 1980, 55, 385– 392.

   OpenUrl
3. 3.↵
   1. Klotz S. A.,
   2. Normand R.,
   3. Silberman R.

   Hepatitis B vaccine in healthy hospital employees. Infection Control 1986, 7, 365– 369.

   OpenUrlPubMed
4. 4.↵
   1. Dimayuga R.,
   2. Scheifele D.,
   3. Bell A.

   Effects of freezing on DTP and DTP-IPV vaccines, adsorbed. Canada Communicable Disease Report 1995, 21-11, 101– 103.

   OpenUrl
5. 5.↵
   1. Dietz V.,
   2. Galazka A.,
   3. van Loon F.,
   4. Cochi S.

   Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems. Bulletin of the World Health Organization 1997, 75, 81– 93.

   OpenUrlPubMedWeb of Science
6. 6.↵
   1. Gold M. S.,
   2. Martin L.,
   3. Nayda C. L.,
   4. Kempe A. E.

   Electronic temperature monitoring and feedback to correct adverse vaccine storage in general practice. Medical Journal of Australia 1999, 171, 83– 84.

   OpenUrlPubMedWeb of Science
7. 7.↵
   1. Burgess M. A.,
   2. McIntyre P. B.

   Vaccines and the cold chain: is it too hot … or too cold? Medical Journal of Australia 1999, 171, 82.

   OpenUrlPubMed
8. 8.↵
   1. Nelson C.,
   2. Froes P.,
   3. Dyck A. M.,
   4. Chavarria J.,
   5. Boda E.,
   6. Coca A.,
   7. Crespo G.,
   8. Lima H.

   Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine 2007, 25 ( 3), 433– 437

   OpenUrlPubMed
9. 9.↵
   1. Milhomme P.

   Cold chain study: danger of freezing vaccines. Canada Communicable Disease Report 1993, 19, 33– 38.

   OpenUrlPubMed
10. 10.↵
    1. Lugosi L.,
    2. Battersby A.

    Transport and storage of vaccines in Hungary: the first cold chain monitor study in Europe. Bulletin of the World Health Organization 1990, 68, 431– 439.

    OpenUrlPubMedWeb of Science
11. 11.↵
    1. Nelson C. M.,
    2. Wibisono H.,
    3. Purwanto H.,
    4. Manssur I.,
    5. Moniaga V.,
    6. Widjaya A.

    Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bulletin of the World Health Organization 2004, 82, 99– 105.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Hanjeet K.,
    2. Lye M. S.,
    3. Sinniah M.,
    4. Schnur A.

    Evaluation of cold chain monitoring in Kelantan, Malaysia. Bulletin of the World Health Organization 1996, 74, 391– 397.

    OpenUrlPubMedWeb of Science
13. 13.↵
    1. Wirkas T.,
    2. Toikilik S.,
    3. Miller N.,
    4. Morgan C.,
    5. Clements C. J.

    A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine 2007, 25 ( 4), 691– 697.

    OpenUrlPubMed
14. 14.↵
    1. Jeremijenko A.,
    2. Kelly H.,
    3. Sibthorpe B.,
    4. Attewell R.

    Improving vaccine storage in general practice refrigerators. British Medical Journal 1996, 312, 1651– 1652.

    OpenUrlFREE Full Text
15. 15.↵
    1. Thakker Y.,
    2. Woods S.

    Storage of vaccines in the community: weak link in the cold chain? British Medical Journal 1992, 304, 756– 758.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Wawryk A.,
    2. Mavromatis C.,
    3. Gold M.

    Electronic monitoring of vaccine cold chain in a metropolitan area. British Medical Journal 1997, 315, 518.

    OpenUrlFREE Full Text
17. 17.↵
    1. Bishai D. M.,
    2. Bhatt S.,
    3. Miller L. T.,
    4. Hayden G. F.

    Vaccine storage practices in pediatric offices. Pediatrics 1992, 89, 193– 196.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Bell K. N.,
    2. Hogue C. J.,
    3. Manning C.,
    4. Kendal A. P.

    Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics 2001, 107, E100.

    OpenUrlCrossRefPubMed
19. 19.↵
    World Health Organization. Guideline for establishing or improving primary and intermediate vaccine stores. WHO/V&B/02.34; p 47.
20. 20.↵
    World Health Organization. Immunization in Practice. WHO/IVB/04.06.
21. 21.↵
    World Health Organization. Product Information Sheets 2000 Edition. WHO/V&B/00.13.
22. 22.↵
    Protection of more cold sensitive vaccines. TechNet21 e-Forum. http://listes.ulaval.ca/listserv/archives/technet21e.html Post00391E (26 November 2001), Post00386E (23 October 2001), Post00400E (19 December 2001), Post00419E (30 January 2002), and Post00428E (19 February 2002).
23. 23.
    World Health Organization. PQS performance specification: Vaccine vial monitor. Specification reference WHO/PQS/E06/IN05.1). Issued on 30 November 2006 (http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e06_in05_1.pdf).
24. 24.↵
    1. Matthias D. M.,
    2. Robertson J.,
    3. Garrison M. M.,
    4. Newland S.,
    5. Nelson C.

    Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 2007, 25, 3980– 3986.

    OpenUrlPubMed
25. 25.↵
    1. Kartoglu U.

    Chilled water packs study. TechNet21 e-Forum. http://listes.ulaval.ca/listserv/archives/technet21e.html Post00502E (20 September 2002).
26. 26.↵
    World Health Organization. Getting started with vaccine vial monitors. WHO/V&B/02.35.
27. 27.↵
    1. Babalioglu N.,
    2. Kartoglu U.

    EVSM assessment: Chisinau primary vaccine store, Republic of Moldova. 6–10 December 2004 (unpublished EVSM external assessment report).
28. 28.↵
    World Health Organization. Study protocol for temperature monitoring in the vaccine cold chain. WHO/IVB/05.01.
29. 29.↵
    World Health Organization. WHO-UNICEF Effective Vaccine Store Management initiative—Model quality plan, Module 2. WHO/IVB/04.18.
30. 30.↵
    1. Soepardi J.

    Personal communication, Jakarta, 3 2004.
31. 31.↵
    1. Ganivet S.

    Personal communication, Geneva, 2 2005.
32. 32.↵
    World Health Organization. PQS performance specification: Vaccine cold box. Specification reference WHO/PQS/E04/CB01.1). Issued on 8 December 2008 (http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_cb01_1.pdf).
33. 33.↵
    World Health Organization. PQS independent type-testing protocol: Vaccine cold box. Product verification protocol WHO/PQS/E04/CB01.VP.1). Issued on 8 December 2008 (http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_cb01_vp1.pdf).
34. 34.↵
    World Health Organization. PQS performance specification: Vaccine carrier. Specification reference WHO/PQS/E04/VC01.1). Issued on 8 December 2008 (http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_vc01_1.pdf).
35. 35.↵
    World Health Organization. PQS independent type-testing protocol: Vaccine carrier. Product verification protocol WHO/PQS/E04/VC01.VP.1). Issued on 8 December 2008 (http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_vc01_vp1.pdf).